Wirksamkeit eines Sabal-Urtica-Kombinationspräparats bei der Behandlung der benignen Prostatahyperplasie (BPH)
- 1 August 1996
- journal article
- Published by Springer Nature in Der Urologe B
- Vol. 36 (4) , 292-300
- https://doi.org/10.1007/s001310050033
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasiaThe Lancet, 1995
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995
- Appropriate indications for prostatectomy in the UK--results of a consensus panel.Journal of Epidemiology and Community Health, 1994
- (10E,12Z)-9-Hydroxy-10,12-octadecadiensäure, ein Aromatase-Hemmstoff aus dem Wurzelextrakt vonUrtica dioicaEuropean Journal of Organic Chemistry, 1991
- Inhibition of 5α-Reductase Activity by Extracts fromSabal serrulataPlanta Medica, 1989
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- Über Inhaltsstoffe von Sabalfrüchten und deren Prüfung auf entzündungshemmende WirkungArchiv der Pharmazie, 1989
- Urtica dioica agglutinin, a new mitogen for murine T lymphocytes: Unaltered interleukin-1 production but late interleukin 2-mediated proliferationCellular Immunology, 1988
- Uroflowmetry in Asymptomatic Elderly MalesBritish Journal of Urology, 1986
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984